Bone morphogenetic proteins and osseointegration: current knowledge - future possibilities.
Huang
Yi-Hao
YH
Polimeni
Giuseppe
G
Qahash
Mohammed
M
Wikesjö
Ulf M E
UM
D016301:Alveolar Bone Loss / Q000188:drug therapy; D000540:Alveolar Ridge Augmentation / Q000379:methods; D000818:Animals; D001843:Bone Cements; D001857:Bone Matrix; D055395:Bone Morphogenetic Protein 1; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D024042:Collagen Type I; D004337:Drug Carriers; D048091:Guided Tissue Regeneration; D006801:Humans; D008666:Metalloendopeptidases / Q000008:administration & dosage / Q000494:pharmacology*; D016348:Osseointegration / Q000187:drug effects*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000008:administration & dosage / Q000494:pharmacology*
C525718:BMP2 protein, human; D001843:Bone Cements; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D024042:Collagen Type I; D004337:Drug Carriers; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; D008666:Metalloendopeptidases; C525705:BMP1 protein, human; D055395:Bone Morphogenetic Protein 1